Peripheral Disruption of the Grb10 Gene Enhances Insulin Signaling and Sensitivity In Vivo

REFERENCES

• Bajaj, M., and R. A. Defronzo. 2003. Metabolic and molecular basis of insulin resistance. J. Nucl. Cardiol. 10:311–323.
   PubMed Web of Science ®Google Scholar
• Bjornholm, M., and J. R. Zierath. 2005. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem. Soc. Trans. 33:354–357.
   PubMed Web of Science ®Google Scholar
• Cariou, B., N. Capitaine, V. Le Marcis, N. Vega, V. Bereziat, M. Kergoat, M. Laville, J. Girard, H. Vidal, and A. F. Burnol. 2004. Increased adipose tissue expression of Grb14 in several models of insulin resistance. FASEB J. 18:965–967.
   PubMed Web of Science ®Google Scholar
• Charalambous, M., F. M. Smith, W. R. Bennett, T. E. Crew, F. Mackenzie, and A. Ward. 2003. Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism. Proc. Natl. Acad. Sci. USA 100:8292–8297.
   PubMed Web of Science ®Google Scholar
• Combs, T. P., A. H. Berg, S. Obici, P. E. Scherer, and L. Rossetti. 2001. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Investig. 108:1875–1881.
   PubMed Web of Science ®Google Scholar
• Cooney, G. J., R. J. Lyons, A. J. Crew, T. E. Jensen, J. C. Molero, C. J. Mitchell, T. J. Biden, C. J. Ormandy, D. E. James, and R. J. Daly. 2004. Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice. EMBO J. 3:582–593.
   Google Scholar
• Daly, R. J., G. M. Sanderson, P. W. Janes, and R. L. Sutherland. 1996. Cloning and characterization of Grb14, a novel member of the Grb7 gene family. J. Biol. Chem. 71:12502–12510.
   Google Scholar
• Deng, Y., S. Bhattacharya, O. R. Swamy, R. Tandon, Y. Wang, R. Janda, and H. Riedel. 2003. Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action. J. Biol. Chem. 78:39311–39322.
   Google Scholar
• Dufresne, A. M., and R. J. Smith. 2005. The adapter protein GRB10 is an endogenous negative regulator of insulin-like growth factor signaling. Endocrinology 146:4399–4409.
   PubMedGoogle Scholar
• Gruppuso, P. A., J. M. Boylan, and C. A. Vaslet. 2000. Identification of candidate growth-regulating genes that are overexpressed in late gestation fetal liver in the rat. Biochim. Biophys. Acta 1494:242–247.
   PubMedGoogle Scholar
• Hikichi, T., T. Kohda, T. Kaneko-Ishino, and F. Ishino. 2003. Imprinting regulation of the murine Meg1/Grb10 and human GRB10 genes; roles of brain-specific promoters and mouse-specific CTCF-binding sites. Nucleic Acids Res. 31:1398–1406.
   PubMed Web of Science ®Google Scholar
• Holt, L. J., and K. Siddle. 2005. Grb10 and Grb14: enigmatic regulators of insulin action—and more? Biochem. J. 388:393–406.
   PubMed Web of Science ®Google Scholar
• Langlais, P., L. Q. Dong, F. J. Ramos, D. Hu, Y. Li, M. J. Quon, and F. Liu. 2004. Negative regulation of insulin-stimulated MAP kinase signaling by Grb10. Mol. Endocrinol. 8:350–358.
   Google Scholar
• Lim, M. A., H. Riedel, and F. Liu. 2004. Grb10: more than a simple adaptor protein. Front. Biosci. 9:387–403.
   PubMed Web of Science ®Google Scholar
• Margolis, B., O. Silvennoinen, F. Comoglio, C. Roonprapunt, E. Skolnik, A. Ullrich, and J. Schlessinger. 1992. High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains. Proc. Natl. Acad. Sci. USA 9:8894–8898.
   Google Scholar
• Mori, K., B. Giovannone, and R. J. Smith. 2005. Distinct Grb10 domain requirements for effects on glucose uptake and insulin signaling. Mol. Cell Endocrinol. 230:39–50.
   PubMedGoogle Scholar
• Mounier, C., L. Lavoie, V. Dumas, K. Mohammad-Ali, J. Wu, A. Nantel, J. J. Bergeron, D. Y. Thomas, and B. I. Posner. 2001. Specific inhibition by hGRB10ζ of insulin-induced glycogen synthase activation: evidence for a novel signaling pathway. Mol. Cell Endocrinol. 173:15–27.
   PubMedGoogle Scholar
• Muse, E. D., S. Obici, S. Bhanot, B. P. Monia, R. A. McKay, M. W. Rajala, P. E. Scherer, and L. Rossetti. 2004. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Investig. 114:232–239.
   PubMed Web of Science ®Google Scholar
• O'Neill, T. J., T. W. Rose, T. S. Pillay, K. Hotta, J. M. Olefsky, and T. A. Gustafson. 1996. Interaction of a GRB-IR splice variant (a human GRB10 homolog) with the insulin and insulin-like growth factor I receptors. Evidence for a role in mitogenic signaling. J. Biol. Chem. 271:22506–22513.
   PubMed Web of Science ®Google Scholar
• Ramos, F. J., P. R. Langlais, D. Hu, L. Q. Dong, and F. Liu. 2006. Grb10 mediates insulin-stimulated degradation of the insulin receptor: a mechanism of negative regulation. Am. J. Physiol. Endocrinol. Metab. 290:E1262–E1266.
   PubMed Web of Science ®Google Scholar
• Riedel, H. 2004. Grb10 exceeding the boundaries of a common signaling adapter. Front. Biosci. 9:603–618.
   PubMed Web of Science ®Google Scholar
• Shen, T. L., and J. L. Guan. 2004. Grb7 in intracellular signaling and its role in cell regulation. Front. Biosci. 9:192–200.
   PubMed Web of Science ®Google Scholar
• Shiura, H., N. Miyoshi, A. Konishi, N. Wakisaka-Saito, R. Suzuki, K. Muguruma, T. Kohda, S. Wakana, M. Yokoyama, F. Ishino, and T. Kaneko-Ishino. 2005. Meg1/Grb10 overexpression causes postnatal growth retardation and insulin resistance via negative modulation of the IGF1R and IR cascades. Biochem. Biophys. Res. Commun. 329:909–916.
   PubMedGoogle Scholar
• Shymko, R. M., P. De Meyts, and R. Thomas. 1997. Logical analysis of timing-dependent receptor signalling specificity: application to the insulin receptor metabolic and mitogenic signalling pathways. Biochem. J. 26:463–469.
   Google Scholar
• Skarnes, W. C., B. A. Auerbach, and A. L. Joyner. 1992. A gene trap approach in mouse embryonic stem cells: the lacZ reported is activated by splicing, reflects endogenous gene expression, and is mutagenic in mice. Genes Dev. 6:903–918.
   PubMed Web of Science ®Google Scholar
• Stein, E. G., T. A. Gustafson, and S. R. Hubbard. 2001. The BPS domain of Grb10 inhibits the catalytic activity of the insulin and IGF1 receptors. FEBS Lett. 493:106–111.
   PubMed Web of Science ®Google Scholar
• Wang, J., H. Dai, N. Yousaf, M. Moussaif, Y. Deng, A. Boufelliga, O. R. Swamy, M. E. Leone, and H. Riedel. 1999. Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis. Mol. Cell. Biol. 19:6217–6228.
   PubMed Web of Science ®Google Scholar
• Wick, K. R., E. D. Werner, P. Langlais, F. J. Ramos, L. Q. Dong, S. E. Shoelson, and F. Liu. 2003. Grb10 inhibits insulin-stimulated IRS/PI 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptor. J. Biol. Chem. 278:8460–8467.
   PubMed Web of Science ®Google Scholar